TickerLeague

Operating Income for Amgen (AMGN)

According to Amgen's latest reported financial statements, the company's current operating income (TTM) is $10.29B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Amgen Inc. logo
Amgen

AMGN

TTM (last 4 quarters)

$10.29B

YoY change

+47.1%

5Y CAGR

+3.2%

Peak year (2025)

$10.68B

Cumulative operating income

$166.74B

Operating Income history chart for Amgen (AMGN) from 1985 to 2025

Operating Income history table for Amgen (AMGN) from 1985 to 2025

Fiscal yearPeriod endedReportedOperating IncomeYoY
2025$10.68B+47.1%
2024$7.26B-8.1%
2023$7.90B-17.4%
2022$9.57B+25.2%
2021$7.64B-16.4%
2020$9.14B-5.5%
2019$9.67B-5.7%
2018$10.26B+2.9%
2017$9.97B+1.8%
2016$9.79B+15.6%
2015$8.47B+36.8%
2014$6.19B+5.5%
2013$5.87B+5.2%
2012$5.58B+29.3%
2011$4.31B-22.2%
2010$5.54B+0.7%
2009$5.51B+5.6%
2008$5.21B+31.0%
2007$3.98B+3.6%
2006$3.84B-20.8%
2005$4.85B+44.8%
2004$3.35B+8.3%
2003$3.09B-493.8%
2002-$785.00M-151.3%
2001$1.53B+11.9%
2000$1.37B+3.3%
1999$1.32B+18.5%
1998$1.12B+20.2%
1997$930.30M+1.6%
1996$916.00M+20.4%
1995$760.80M+8.9%
1994$698.50M+26.7%
1993$551.20M+10.7%
1992$498.10M+303.6%
1991$123.40M+141.5%
1990$51.10M
1988-$4.80M-14.3%
1987-$5.60M+300.0%
1986-$1.40M+55.6%
1985-$900,000

Operating Income values are taken from Amgen's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, Amgen (AMGN) operating income totalled $10.68B – surged 47.1% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Amgen operating income compounded at +3.2% per year, with the latest reading among the more recent periods of the dataset.

The dataset's maximum operating income sits at $10.68B (2025); the minimum reading of -$785.00M dates to 2002.

Within Healthcare, Amgen (AMGN) ranks 8th among 8 peers we track. The peer median for operating income is $22.84B.

Amgen Operating Income by Year

Amgen Operating Income 2025: $10.68B

Amgen operating income in 2025 was $10.68B, surged 47.1% from 2024. This figure represents the highest annual value in the available history.

Amgen Operating Income 2024: $7.26B

Amgen operating income in 2024 was $7.26B, declined 8.1% below 2023.

Amgen Operating Income 2023: $7.90B

Amgen operating income in 2023 was $7.90B, declined 17.4% below 2022.

Amgen Operating Income 2022: $9.57B

Amgen operating income in 2022 was $9.57B, grew 25.2% from 2021.

Amgen Operating Income 2021: $7.64B

Amgen operating income in 2021 was $7.64B.

See more financial history for Amgen (AMGN).

Sector peers — Operating Income

Companies in the same sector as Amgen, ranked by their latest operating income.

CompanyOperating IncomeSector
Novo Nordisk A/S (NVO)$127.66BHealthcare
Eli Lilly and Company (LLY)$29.70BHealthcare
Merck & Co., Inc. (MRK)$26.78BHealthcare
Johnson & Johnson (JNJ)$25.60BHealthcare
AbbVie Inc. (ABBV)$20.09BHealthcare
UnitedHealth Group Incorporated (UNH)$18.96BHealthcare
AstraZeneca PLC (AZN)$13.74BHealthcare
Thermo Fisher Scientific Inc. (TMO)$8.11BHealthcare

Frequently asked questions

What is Amgen's operating income?

Latest reported operating income for Amgen (AMGN) is $10.29B (period ending December 31, 2025).

How has Amgen operating income changed year-over-year?

Amgen (AMGN) operating income changed +47.1% year-over-year on the latest annual filing.

What is the long-term growth rate of Amgen operating income?

Amgen (AMGN) operating income compound annual growth rate is +3.2% over the most recent 5 years available.

When did Amgen operating income hit its highest annual value?

Amgen operating income reached its highest annual value of $10.68B in 2025.

What was Amgen operating income in 2024?

Amgen (AMGN) operating income in 2024 was $7.26B.

What was Amgen operating income in 2025?

Amgen (AMGN) operating income in 2025 was $10.68B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.